Business
Weight-loss pill approval set to accelerate food industry product overhauls
NEW YORK, Dec 24 (Reuters) - Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, appetite-suppressing GLP-1 pills become available in January, analysts say. More Americans are expected to try the drugs as a pill rather than as a shot because the medication will be cheaper and many patients are hesitant to inject themselves.
Business
Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
Dec 24 () - Shares of Agios Pharmaceuticals jumped nearly 12% premarket on Wednesday after the U. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
Business
Sanofi to acquire hepatitis B vaccine maker Dynavax for $2.2 billion
Dec 24 (Reuters) - Sanofi will buy U. vaccines company Dynavax Technologies for around $2.
Business
Lilly, Novo lock horns in India's obesity drug race
HYDERABAD, India, Dec 24 () - Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market before cheaper generic versions hit shelves in March next year. Novo's strategy emphasizes price cuts and accelerated launches, while Lilly's products benefitted from hitting the market early.
Business
Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could potentially expand access to millions of patients and give the Danish company a much-needed fillip in the red-hot market. The first GLP-1 pill specifically for obesity, also branded as Wegovy, is a 25-mg oral formulation of semaglutide, the active ingredient in the blockbuster injectable version.
Business
I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
Alex Yang details founding an AI startup with other high schoolers worldwide to improve Alzheimer's diagnostics.
Business
Rick Steves' Favorite Time To Visit Spain Has Lower Prices And Fewer Crowds
Rick Steves is the guy to go to for budget traveling tips, and if you've set your eyes on Spain, this is the time he believes is best to visit.
Business
US FDA grants market authorization to six on! PLUS nicotine pouch products
Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on. PLUS nicotine pouch products, through a pilot program aimed to fast-track reviews of such products.
Business
Cocoa Prices Undercut Amid the Prospects of Abundant Supplies
March ICE NY cocoa (CCH26 ) on Friday closed down -89 (-1.50%), and March ICE London cocoa #7 (CAH26 ) closed down -43 (-0.99%). Cocoa prices extended this week's losses on Friday, with NY cocoa falling to a 1.5-week low. Favorable weather in West Africa is expected to boost yields...
Business
BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
Dec 19 () - BioMarin Pharmaceutical said on Friday it would acquire Amicus Therapeutics for about $4.8 billion, expanding its presence in rare metabolic diseases.